Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Gullibility test

Why did you omit the first qualifying condition?:

The company's common equity public float was $75 million or more as of the last business day of its most recently completed second fiscal quarter

.

.

.

Be well

Share
New Message
Please login to post a reply